Identifying antibody features to predict how they interact with viruses
High-throughput identification of antibody features for sequence-based epitope prediction
This study is looking at how our immune system's antibodies find and attach to parts of the flu virus, with the goal of helping create better vaccines and treatments for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-11111632 on NIH RePORTER |
What this research studies
This research focuses on understanding how antibodies, which are crucial for our immune response, recognize and bind to specific parts of viruses, particularly the influenza A virus. By analyzing the genetic sequences of antibodies, the researchers aim to develop a high-throughput method to predict which parts of the virus these antibodies will target. This could lead to better vaccine and therapeutic designs by providing insights into how to enhance the effectiveness of antibodies against infections. The study will utilize advanced screening techniques to characterize these interactions in detail.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are at risk of influenza infections or those who have a history of severe reactions to the virus.
Not a fit: Patients who are not affected by influenza or have no history of immune response issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccines and treatments for influenza and potentially other viral infections.
How similar studies have performed: Other research has shown promise in using similar high-throughput methods to understand antibody interactions, indicating that this approach could be effective.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Wu, Nicholas C. — University of Illinois at Urbana-Champaign
- Study coordinator: Wu, Nicholas C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.